- Home
- BNTX vs CAH Comparison
BNTX vs CAH Comparison
Compare BNTX & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTX | CAH |
|---|---|---|
| Founded | 2008 | 1979 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 49.4B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | BNTX | CAH |
|---|---|---|
| Price | $93.14 | $204.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $137.40 | ★ $200.25 |
| AVG Volume (30 Days) | 1.5M | ★ 2.5M |
| Earning Date | 11-03-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 1.01% |
| EPS Growth | N/A | ★ 27.25 |
| EPS | N/A | ★ 6.63 |
| Revenue | $3,698,814,972.00 | ★ $234,310,000,000.00 |
| Revenue This Year | $2.36 | $16.60 |
| Revenue Next Year | N/A | $8.92 |
| P/E Ratio | ★ N/A | $30.63 |
| Revenue Growth | 3.70 | ★ 4.39 |
| 52 Week Low | $81.20 | $115.00 |
| 52 Week High | $129.27 | $214.93 |
Technical Indicators
Market Signals| Indicator | BNTX | CAH |
|---|---|---|
| Relative Strength Index (RSI) | 38.27 | 64.57 |
| Support Level | $91.11 | $195.54 |
| Resistance Level | $93.76 | $200.83 |
| Average True Range (ATR) | 2.08 | 3.11 |
| MACD | -0.19 | -0.76 |
| Stochastic Oscillator | 23.55 | 88.22 |
Price Performance
Historical ComparisonAbout BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.